Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Nov 26, 2014; 6(11): 1218-1222
Published online Nov 26, 2014. doi: 10.4330/wjc.v6.i11.1218
Published online Nov 26, 2014. doi: 10.4330/wjc.v6.i11.1218
Surgical management of moderate ischemic mitral valve regurgitation: Where do we stand?
Khalil Fattouch, Department of Cardiovascular Surgery, GVM Care and Research, Maria Eleonora Hospital, 90100 Palermo, Italy
Sebastiano Castrovinci, Giacomo Murana, Department of Cardiovascular Surgery, University of Bologna, 40138 Bologna, Italy
Marco Moscarelli, Cardiothoracic Surgery Department, Hammersmith Hospital, Imperial College, London W12 0HS, United Kingdom
Giuseppe Speziale, Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, 70124 Bari, Italy
Author contributions: Fattouch K, Castrovinci S and Murana G contributed equally to this work and wrote the manuscript; Moscarelli M contributed to the editing of the manuscript; Speziale G contributed to the reviewing of the manuscript.
Correspondence to: Khalil Fattouch, MD, PhD, Chief of Cardiovascular Surgery Unit, Department of Cardiovascular Surgery, GVM Care and Research, Maria Eleonora Hospital, Viale Regione Siciliana 1571, 90100 Palermo, Italy. khalilfattouch@hotmail.com
Telephone: +39-91-6981111 Fax: +39-91-6761612
Received: June 2, 2014
Revised: September 16, 2014
Accepted: October 1, 2014
Published online: November 26, 2014
Processing time: 181 Days and 16.5 Hours
Revised: September 16, 2014
Accepted: October 1, 2014
Published online: November 26, 2014
Processing time: 181 Days and 16.5 Hours
Core Tip
Core tip: Moderate ischemic mitral regurgitation should always be considered in patients undergoing other cardiac surgery. Restrictive anuloplasty alone fails as valid treatment because often associated with persistence and high recurrence rate of mitral regurgitation due to continuous ventricular remodeling. Probably more aggressive repair procedures addressing the subvalvular mitral apparatus would help to find more durable results for this complex disease. In the next future new preoperative predictors of increased MR recurrence are certainly needed to find an individual time period of treatment in each patients with moderate ischemic mitral regurgitation.